InsidersTradesSigma
네오팜 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 네오팜 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 네오팜 has logged 23 reports. Market capitalisation: €295.9bn. The latest transaction was reported on 5 March 2026 (Purchase). Among the most active insiders: 잇츠한불. All data is free.
23
Insider Decl.
n/a
Thresholds
€2m
18 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 705 of 27,878 companies
82.9
score / 100
Value78
Quality87
FCF yld9.1%
Earn yld9.4%
EV/EBITDA8.4x
ROE·
Gross mgn65%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2026
Declarations23 total
164,396 sharesKRXDART:20260305000589
803,389 sharesKRXDART:20260202000117
23 of 23 declarations
About 네오팜
Neopharm is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX market.